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Abstract
Identifying gene-environment interactions (GxEs) contributing to human cardiometabolic 
disorders is challenging. Here we apply a reverse GxE candidate search by deriving candidate 
variants from promoter-enhancer interactions that respond to dietary fatty acid challenge through 
altered chromatin accessibility in human primary adipocytes. We then test all variants residing in 
the lipid-responsive open chromatin sites within adipocyte promoter-enhancer contacts for 
interaction effects between the genotype and dietary saturated fat intake on body mass index 
(BMI) in the UK Biobank. We discover 14 novel GxE variants in 12 lipid-responsive promoters, 
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including well-known lipid genes (LIPE, CARM1, and PLIN2) and novel genes, such as LDB3, 
for which we provide further functional and integrative genomics evidence. We further identify 24 
GxE variants in enhancers, totaling 38 new GxE variants for BMI in the UK Biobank, 
demonstrating that molecular genomics data produced in physiologically relevant contexts can 
discover new functional GxE mechanisms in humans.
Introduction
Cardiometabolic disorders develop as a result of genetic predisposition, environmental 
factors, and their interactions1,2. Genome-wide association studies (GWAS) have detected 
additive genetic effects for these traits, but we still have not identified the biological 
mechanisms explaining how genetic variation is involved in the increasing prevalence of the 
obesogenic cardiometabolic disorders. Some examples of gene-environment interactions 
(GxEs) are emerging, including for instance, the highly replicated BMI risk variant 
rs9939609 in the intron of the FTO gene that exhibits a significant interaction with physical 
activity on BMI3. However, overall there are scarce replicated GxE signals for 
cardiometabolic disorders in humans1. It has remained challenging to identify these signals 
due to small cohort sizes and poorly standardized human environmental phenotypes. Even 
with large cohorts such as the UK Biobank4, the statistical power to detect GxEs using a 
genome-wide agnostic search is limited due to the small effect sizes of GxEs and heavy 
multiple testing penalties. Furthermore, once GxE signals have been detected, the 
mechanisms underlying the associations remain unclear, warranting further fine-mapping 
studies.
To systematically identify genes involved in GxEs, we set out to quantify molecular genomic 
responses to saturated and monounsaturated fatty acid challenge in human primary 
adipocytes, as a cellular model of dietary fat intake in this key adipose tissue cell type. We 
measured differences in chromatin accessibility and searched the whole genome for 
chromosomal interactions between lipid-responsive gene promoters and enhancers to shed 
new light onto the genomic molecular mechanisms relevant for lipid responses in human 
adipocytes. We hypothesized that these genomic responses then provide targeted regions 
harboring candidate genetic variants for GxE analysis in the large UK Biobank cohort4. This 
should restrict the multiple testing burden hampering the typical agnostic genome-wide GxE 
analysis, and expand our knowledge of the true environmental exposures responsible for the 
GxE signals, thereby revealing the underlying functional mechanisms. Thus, integrating 
context-specific molecular genomics with environmental phenotypes and clinical outcome 
data in the UK Biobank should help elucidate molecular mechanisms that respond to 
obesogenic cellular context and contribute to cardiometabolic traits in humans.
Results
Adipocyte-accessible chromatin identifies regulatory regions
To obtain human primary adipocytes for the study of lipid effects on chromatin dynamics, 
we first differentiated human primary white preadipocytes to adipocytes in vitro (Figure 1a). 
We performed ATAC-seq5 on three biological replicates of the preadipocytes and adipocytes 
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to identify open chromatin regions that are differentially accessible between the two cell 
types (Figure 1b; Supplementary Table 1; Supplementary Table 2). The 50,336 ATAC-seq 
peaks that were more accessible in human primary adipocytes (i.e. “adipocyte-accessible”) 
included the promoters of adipocyte-specific genes ADIPOQ and PPARGC1A (Figure 1c,d), 
providing evidence that we successfully differentiated the adipocytes in vitro. To explore 
whether the adipocyte-accessible peaks harbor transcription factor (TF) motifs relevant for 
adipocyte biology, we performed TF motif enrichment analyses using HOMER6. We found 
that the top enriched motif corresponds to the CCAAT-enhancer binding protein alpha 
(CEBPA) transcription factor motif (Figure 1b), an important regulator of the later stages of 
adipogenesis7. We then classified the adipocyte-accessible peaks into functional genomic 
annotations8, and observed that the adipocyte-accessible peaks fell more often into adipocyte 
enhancers and less frequently into quiescent regions when compared with the full peak set or 
preadipocyte-accessible peaks (Supplementary Figure 1). Taken together, these results 
provide evidence that the in vitro differentiation of adipocytes leads to an increase in 
chromatin accessibility in regions important for genomic regulation in adipocytes.
Genomic responses to dietary lipids in human adipocytes
We next searched for genomic regions harboring regulatory elements that mediate adipocyte 
responses to the intake of different dietary lipids, by treating the adipocytes with the 
saturated fatty acid (SFA), palmitic acid (C16:0), or the monounsaturated fatty acid 
(MUFA), oleic acid (C18:1 cis-9), and then performing ATAC-seq on three biological 
replicates per condition (Figure 2a). We found that treatment with either of these fatty acids 
resulted in increased staining with oil red o, which incorporates into neutral lipids, indicating 
that the lipid challenge resulted in increased storage of fatty acids in the lipid droplets of the 
cells (Supplementary Figure 2). We identified 1,653 ATAC-seq peaks that were differentially 
accessible in the lipid-challenged human primary adipocytes, referred to as lipid-responsive 
peaks (Figure 2b; Supplementary Figure 3; Supplementary Table 3; Supplementary Table 4). 
We cross-referenced these lipid-responsive peaks with the adipocyte-accessible peaks 
(Figure 1), and found that the 570 adipocyte-accessible, lipid-responsive peaks fell mostly 
into enhancer and promoter annotations in adipocytes8, in line with their likely importance 
in environmental responses and regulation of gene expression in adipocytes (Figure 2b; 
Supplementary Figure 4).
Noteworthy, we found that 453 of the 1,653 lipid-responsive peaks were not detected as 
open chromatin in the initial ATAC-seq data created in untreated adipocytes and 
preadipocytes (Figure 2b). These context-dependent open chromatin regions fell into a 
higher percentage of quiescent annotations imputed from data created in unchallenged 
adipocytes8 (Supplementary Figure 4). This indicates that genomic regions that are not 
normally open and accessible for TF binding in untreated, steady-state adipocytes or 
preadipocytes became activated in adipocytes under lipid challenge conditions.
When we stratified the SFA and MUFA treatment responses by adipocyte-accessible or 
context-dependent open chromatin regions, we found that the SFA treatment effects in 
context-dependent open chromatin regions were shifted towards increased accessibility 
(Figure 2c,d). This is in contrast to the MUFA responses, which were generally evenly 
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distributed between the peaks with decreased and increased accessibility (Figure 2c,d). This 
suggests that the quality of fatty acids can result in distinct signaling effects on genome-level 
responses to lipid intake in adipocytes, and particularly SFA intake seems to activate regions 
of the genome that are normally inactive in untreated adipocytes.
Upon closer examination, we found 14 context-dependent peaks, exhibiting increased 
accessibility in the SFA-treated adipocytes, falling into a ~50 kb region on chromosome 10 
(Figure 2e). The locus contains a total of 15 lipid-responsive peaks, which span the entirety 
of the glycerol-3-phosphate acyltransferase, mitochondrial (GPAM) gene (Figure 2e). 
GPAM prefers saturated fatty acid substrates, and has been associated with serum lipid 
traits9–11 [triglycerides (TGs), high-density lipoprotein cholesterol (HDL), low-density 
lipoprotein cholesterol (LDL), and total cholesterol (TC)] and serum alanine 
aminotransferase (ALT), which is a biomarker for liver health12, in previous GWAS 
studies13. These earlier GWAS associations at this locus, combined with the strong genomic 
response to SFA treatment in adipocytes observed here, suggest that dysregulation of this 
important lipogenic pathway in adipocytes could contribute to obesogenic cardiometabolic 
disorders, such as dyslipidemias and non-alcoholic fatty liver disease (NAFLD).
Lipid-responsive gene promoters in chromosomal interactions
To identify genes under transcriptional regulation via chromosomal interactions, we 
performed promoter Capture Hi-C (pCHi-C)14 in the lipid-challenged human adipocytes in 
two biological replicates per condition (Supplementary Table 5). We identified 264 lipid-
responsive ATAC-seq peaks that fall within adipocyte chromosomal interactions. To test 
whether these interacting, lipid-responsive regions of the genome harbor motifs for TFs that 
are important for lipid metabolism, we performed TF motif enrichment analysis6 comparing 
the lipid-responsive to non-lipid-responsive peaks within the chromosomal interactions. We 
found that peroxisome proliferator-activated receptor gamma (PPARG), an important TF in 
adipogenesis and lipid uptake, and its co-factor retinoid X receptor (RXR), are within the top 
10 highest enriched motifs (Figure 3a; Supplementary Table 6). This indicates that the lipid-
responsive sites in adipocyte promoter-enhancer contacts represent genomic regions that are 
important for mediating cellular responses to the lipid uptake.
To identify the target genes of the adipocyte responses to lipid challenge, we first focused on 
the interacting promoters from the adipocyte pCHi-C (Figure 3b), as promoters are more 
highly enriched for SNPs that contribute to the heritability of local gene expression15,16. The 
86 interacting pCHi-C baits represent 154 gene promoters given that the resolution of pCHi-
C interaction data depends on the restriction sites in the genome (Figure 3b; Supplementary 
Table 7). We performed a KEGG pathway enrichment analysis17 on the set of 154 
interacting lipid-responsive target genes, which resulted in 2 significantly enriched pathways 
of amino acid metabolism (FDR < 0.05) (Supplementary Table 8).
As energy homeostasis is important for survival, we hypothesized that the 154 gene regions 
responsible for mediating the effects of lipid uptake in adipocytes might exhibit differences 
in the level of conservation when compared to other genes in the genome. We therefore 
obtained an average conservation score for the 114 protein-coding genes among the 154 
genes (gene body +/− 500 kb) using PHASTcons18, and found that the lipid-responsive 
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protein-coding genes have higher conservation scores across placental mammals than all 
other protein-coding genes in the human genome (p=0.020) (Figure 3c).
We further investigated whether these lipid-responsive genes exhibit constraints on genetic 
mutations, using the probability of the gene being loss-of-function intolerant (pLI), defined 
in Lek et al.19 as genes that are highly unlikely to exhibit protein-truncating mutations in 
humans. We found that of the genes for which pLI scores are available (n=104)19, 27 genes 
(26.0%) are considered LoF-intolerant. Given that 17.7% of all genes are considered LoF-
intolerant, the pLI for lipid-responsive genes is higher than expected by chance alone 
(p=0.022) (Figure 3d). Taken together, we identified 154 genes with lipid-responsive 
promoters in chromosomal interactions that are less tolerant of LoF variants, and reside 
within genomic regions that are more conserved than expected by chance alone.
Genes that interact with lipid-responsive enhancers
We next tested whether the genes that interact with lipid-responsive enhancers exhibit 
similar characteristics as the genes that have lipid-responsive promoters. We first found that 
169 lipid-responsive enhancers interact with 223 promoter-containing HindIII baits in the 
adipocyte pCHi-C (Supplementary Figure 5). Because multiple gene promoters can be 
captured within a single HindIII fragment, these 223 baits represent 323 gene promoters 
(Supplementary Figure 5; Supplementary Table 9). When we tested whether these 323 genes 
are enriched in any KEGG pathways, we did not find any functional pathways passing 
multiple testing correction. This may be due to the fact that, on average, each lipid-
responsive enhancer interacts with ~2 promoters (Supplementary Figure 5), thus leading to 
ambiguities regarding which gene may be the true target of the lipid signaling response.
We further determined whether the genes that interact with lipid-responsive enhancers 
exhibit mutational constraints by checking whether the cis regions (gene body +/− 500 kb) 
of the protein-coding genes in this set (n=217) have higher average conservation scores than 
all other protein-coding genes in the genome. Contrary to what we observed for the genes 
with lipid-responsive promoters (Figure 3c), we did not observe a significant difference in 
the conservation scores for genes that interact with lipid-responsive enhancers 
(Supplementary Figure 5). Interestingly, of the enhancer-interacting genes that have a pLI 
score (n=207)19, 50 (24.2%) are LoF-intolerant, which is significantly higher than would be 
expected by chance alone (p=0.014) (Supplementary Figure 5). Taken together, these results 
are consistent with more moderate functional significance of the genes that interact with 
lipid-responsive enhancers when compared to the genes with lipid-responsive ATAC-seq 
peaks in their promoters.
Lipid responses contribute to serum lipid trait heritability
We hypothesized that the genes we were able to identify through the lipid-responsive 
promoter-enhancer interactions might highlight important genomic regions that contribute to 
the heritability of cardiometabolic traits. We first found that 5 lipid-responsive gene 
promoters and 3 lipid-responsive enhancers within adipocyte chromosomal interactions 
contain SNPs with genome-wide-significant (p < 5×10−8) associations with serum lipid 
traits, identified in a meta-GWAS of ~180,000 individuals11 (Table 1; Supplementary Table 
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10). One of the lipid-responsive GWAS loci is the well-known nutritional response locus 
containing the fatty acid desaturase (FADS1/2/3) gene cluster on chromosome 11 (Figure 
4a), which harbors SNPs that have been associated with multiple cardiometabolic traits20 
and intermediate phenotypes21,22. In line with the observed pleiotropy among the serum 
lipid-associated SNPs, the lipid-responsive peak in the FADS2 promoter contains GWAS 
SNPs for all tested serum lipid traits11 (LDL, HDL, TC, TG), with the strongest signal 
coming from rs99780 for LDL (p=2.39×10−21; Table 1). Notably, the observed open 
chromatin peak in FADS2 is more accessible in the palmitic acid treatment when compared 
with the oleic acid treatment (Figure 4b; FDR=0.0021), corresponding to the fact that one of 
the FADS2 substrates is palmitic acid23.
This response at a serum lipid GWAS locus is reminiscent of the strong SFA response at the 
GPAM gene (Figure 2e); in fact, all five serum lipid GWAS SNPs in lipid-responsive gene 
promoters within chromosomal interactions exhibited increased chromatin accessibility, 
specifically in response to SFA intake in adipocytes (Supplementary Table 11). The lipid-
responsive enhancers that interact with gene promoters in the adipocyte pCHi-C exhibited a 
similar trend (Supplementary Table 12). These results suggest that environmental responses, 
particularly to saturated fat intake, explain functional mechanisms at these lipid GWAS loci.
Since sub-genome-wide significant signals likely also contribute to the heritability of 
cardiometabolic disorders, particularly with the added effect of relevant environmental 
stimuli, we wanted to test the combined effect of all variants in our lipid-responsive regions 
while still accounting for the linkage disequilibrium (LD) between them. We therefore tested 
whether genetic variants in the cis regions (gene body +/− 500 kb) of all 154 lipid-
responsive, interacting promoters, contribute significantly to the heritability of serum lipid 
levels. For these analyses, we used the LD Score partitioned heritability method24, and 
GWAS summary statistics from the high-powered meta-GWAS for serum lipid traits11. We 
found that 2.9% of all variants reside within the cis regions of the 154 genes, and these 
variants contribute significantly to the heritability of the four lipid traits (0.0088 ≤ p ≤ 0.045 
with an average enrichment of 2.915; Supplementary Table 13). In contrast, 5.5% of all 
variants reside within the cis regions of genes with promoters interacting with lipid-
responsive enhancers. These SNPs contribute significantly to the heritability of HDL, but not 
to the other lipid traits (Supplementary Table 14). This is consistent with a more diffuse 
overall functional characterization of the genes that interact with lipid-responsive enhancers 
when compared to the genes with lipid-responsive open chromatin in their promoters. 
Overall, these results indicate that the adipocyte lipid-responsive, interacting loci are 
important in modulating serum lipid levels in humans, and provide evidence that variants in 
these regions may have a role in GxEs in humans.
Lipid responses identify novel GxEs for BMI in UK Biobank
The large, deeply phenotyped UK Biobank4 cohort can provide a valuable resource for GxE 
studies, particularly since the participants’ environmental phenotypes have been 
characterized in a systematic manner. Saturated fat intake has known adverse effects on 
cardiometabolic disorders25–27, and we present evidence here in human adipocytes for an 
enhanced effect of human adipocyte genomic responses to SFA intake on cardiometabolic 
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traits relative to MUFA (Figure 2c–e; Supplementary Table 11; Supplementary Table 12). To 
maximize the number of individuals for which phenotypes are available, as well as aim for 
the most relevant environment and cardiometabolic outcome, we used dietary intake of 
saturated fat (24-hour recall) as the environmental variable, and body mass index (BMI) as 
the outcome for our GxE analysis.
We first tested whether there are any genome-wide significant signals for GxEs using 
167,908 individuals in the UK Biobank. We corrected the BMI measurements for array type, 
sex (inferred), age (when attended assessment center), age2, the assessment center ID, and 
genetic principle components of 1-20, as done previously28. We then inverse normal 
transformed the residuals to account for mean-variance relationships in the phenotype, 
which has been shown previously to impact the GxE signals29. As can be seen in the Q-Q 
plot from the genome-wide scan for GxEs, there is no evidence of genomic inflation in the 
GxE linear model (Supplementary Figure 6). Furthermore, the fact that we were not able to 
detect any genome-wide significant signals in this genome-wide GxE analysis (see Equation 
1 in Methods) (Supplementary Figure 6) supports the feasibility of our reverse GxE 
candidate search approach, which identifies prior functional candidates for GxE analyses 
from molecular genomics data produced in biologically relevant conditions.
We have provided evidence that lipid challenge in adipocytes highlights important regions of 
the genome that respond to environmental cues and contribute to the heritability of 
cardiometabolic traits. Thus, these regions provide strong candidates for GxEs in humans. 
The 154 promoters in chromosomal interactions contained 91 lipid-responsive open 
chromatin sites (Figure 3b), and we determined that 75 of these 91 candidate regions 
contained variants with a minor allele frequency (MAF) > 0.05 in the set of 167,908 
individuals for which we have both dietary saturated fat intake and BMI phenotypes 
available (Supplementary Table 15).
We performed the GxE analysis by incorporating all SNPs residing in the open chromatin, 
lipid-responsive promoter regions (n=290; Supplementary Table 15) into a multi-variable 
linear model (see Equation 2 in Methods). This resulted in the identification of 14 significant 
non-redundant GxE SNPs (LD r2 < 0.2) in 12 interacting promoters, including novel GxE 
SNPs at the promoters of well-known lipid genes, hormone-sensitive lipase (LIPE), 
coactivator-associated arginine methyltransferase 1 (CARM1) and perilipin 2 (PLIN2) 
(Table 2; Supplementary Table 16).
We next performed a similar GxE analysis on all SNPs at the lipid-responsive enhancers that 
interact with gene promoters in the human adipocytes. Of the 173 lipid-responsive regions 
within the interacting enhancers (Supplementary Figure 5), 142 contained SNPs with a MAF 
> 0.05 in the 167,908 individuals in the UK Biobank (Supplementary Table 17). We used the 
same multi-variable linear model approach to test these SNPs (n=410) for an interaction 
with saturated fat intake effect on BMI, and found 24 non-redundant (LD r2 < 0.2) 
significant GxE SNPs (Supplementary Table 18). Due to the fact that enhancer fragments 
can interact with more than one promoter-containing pCHi-C bait, these 24 non-redundant 
SNPs interact with a total of 27 promoter baits in human adipocytes (Supplementary Table 
18).
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Identifying altered chromatin states at the GxE SNP sites
The differential chromatin accessibility in response to lipid challenge in adipocytes likely 
stems from altered chromatin states, such as TF binding or histone modifications. This is 
supported by our result that the lipid-responsive regions within chromosomal interactions are 
enriched for important lipid metabolism TF motifs (Figure 3a; Supplementary Table 6). To 
determine the predicted allelic effect of the GxE SNPs on these chromatin features, we used 
the DeepSEA tool30, which applies a deep learning algorithm to publicly available 
molecular genomics data to predict chromatin features based on genomic sequence in silico. 
Notably, 11 of the 20 (55%) GxE SNPs in lipid-responsive promoters had a functional 
significance score of <0.05, and the predicted impact of the GxE SNPs included differential 
binding of RXRA (Supplementary Table 19). Conversely, only 5 of the 26 (19%) GxE SNPs 
in lipid-responsive enhancers had functional significance scores of <0.05 (Supplementary 
Table 20). It is worth noting that the publicly available data used to train the DeepSEA 
neural net do not include molecular genomics data for adipocytes or adipose tissue. 
Therefore, the GxE SNPs may fall into cell-type-specific regulatory elements, and thus 
disrupt chromatin features that cannot be predicted through this tool.
To obtain further evidence for the function of the GxE SNPs in adipose tissue, we checked 
whether the GxE SNPs affect local gene expression in human adipose tissue as cis 
expression quantitative trait loci (cis-eQTLs), and whether the cis-eQTL target gene is the 
same gene that harbors the lipid-responsive promoter and GxE signal. We found that 3 of the 
12 genes with lipid-responsive promoters harboring GxE signals are also regulated in cis by 
their GxE SNP at the genome-wide significant level in the subcutaneous adipose RNA-seq 
data (n=335) of the Finnish METSIM cohort15,31 (Table 2; Supplementary Table 16). These 
genes are glioma tumor suppressor candidate region gene 2 protein (GLTSCR2), PLIN2, and 
LIM domain binding 3 (LDB3). Additionally, 2 of the 27 genes interacting with lipid-
responsive enhancers were regulated in cis by their interacting GxE SNP at the genome-wide 
significant level in human subcutaneous adipose tissue (Supplementary Table 18): 
thrombospondin 2 (THBS2) and Cbp/P300 interacting transactivator with glu/asp rich 
carboxy-terminal domain 4 (CITED4).
We further checked whether the imputed cis expression values for these 5 cis-eQTL target 
genes (eGenes) are correlated with BMI or other obesogenic cardiometabolic phenotypes, as 
determined through transcriptome-wide association analysis (TWAS)32,33. The LDB3 
adipose expression model was strongly associated with BMI, arm fat percentage (genome-
wide significant TWAS scores > 5.0), and other related body fat distribution phenotypes 
(TWAS scores > 4.0)29. Furthermore, the tibial artery expression model for LDB3 was also 
significantly associated with high blood pressure and cardiovascular disease (genome-wide 
significant TWAS scores < −5.0)29. None of the other eGene expression models were 
associated with cardiometabolic phenotypes at the genome-wide significant level.
Since the adipose expression models of LDB3 were significantly associated with BMI in 
TWAS29, we followed up on the most significant GxE SNP in the LDB3 lipid-responsive 
peak (Figure 5a), rs10788522, which is also an adipose cis-eQTL SNP for LDB3 in the 
METSIM cohort (Table 2). As is evidenced by the ATAC-seq reads intersecting with the 
SNP rs10788522 (Figure 5b), we found, using electrophoretic mobility shift assays 
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(EMSAs), that adipocyte nuclear protein binds this GxE SNP (Figure 5c; Supplementary 
Table 21). Whereas LDB3 is expressed in the subcutaneous adipose tissue from the 
METSIM cohort, as well as the Gene Tissue Expression (GTEx) consortium34, we could not 
reliably detect LDB3 expression using quantitative PCR (qPCR) in the lipid-challenged 
adipocytes (data not shown). We therefore checked whether any publicly available datasets 
analyzed the transcriptome of sorted cells from human adipose tissue. In previously 
published microarray datasets (GSE80654, GSE100795) from human adipose biopsies in 
which the adipocytes were collected and the remaining cell types separated by fluorescence-
activated cell sorting (FACS), LDB3 is expressed in human adipocytes at a comparable level 
to the LDB3 expression in the other adipose cell types35,36. Taken together with our result 
that the LDB3 promoter responds to lipid uptake in adipocytes, these data support the 
conclusion that the GxE SNP rs10788522 regulates LDB3 adipocyte expression in response 
to dietary saturated fat, and that the interaction has a protective (BMI-lowering) effect (Table 
2). Altogether, we provide a mechanistic interpretation and fine-mapping of a causal GxE 
SNP rs10788522, narrowing it to the promoter of LDB3 that exhibits differential open 
chromatin in response to lipid challenge in human adipocytes (Figure 5; Figure 6).
Discussion
It is well-established that environment plays a significant role in the development of 
cardiometabolic disorders. However, GxEs have been challenging to detect due to both the 
lack of extensive study cohorts with sufficient statistical power to detect the small GxE 
effects, and complexity of environmental exposures that are difficult to measure in a 
standardized way in humans1. Systematic identification of the effects of defined 
environmental contributions to cardiometabolic disorders is thus necessary to effectively 
move toward the promise of precision medicine. Through our integration of context-specific 
molecular genomics data with human epidemiologic and clinical outcome data in the UK 
Biobank, we provide much-needed information of how the chromatin landscape of human 
adipocytes responds to external environmental signals, and identify the molecular basis of 
novel GxEs in humans (Figure 6).
We reversed the typical approach of selecting candidate GxEs among GWAS SNPs, by first 
scanning the genome for molecular responses to controlled environmental stimuli, using a 
cellular model of saturated or monounsaturated fat intake effects on chromatin dynamics in 
human primary adipocytes. Through our integration of chromatin accessibility and 
chromosomal interactions in the lipid-challenged adipocytes, we identified lipid-responsive 
open chromatin within promoter-enhancer contacts, effectively identifying candidate GxE 
genes with strong prior evidence of genomic regulation in response to fatty acid uptake and 
processing in human adipocytes. This systematic approach culminated in testing a total of 
700 SNPs in the accessible, lipid-responsive chromatin regions for interactions with dietary 
saturated fat intake affecting BMI in the UK Biobank4. This led to the identification of 14 
significant, non-redundant GxE SNPs in 12 gene promoter regions and 24 non-redundant 
GxE SNPs in 20 enhancers, representing novel gene-diet interactions affecting BMI (Figure 
6).
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We observed that the LDB3 gene is regulated in cis by its promoter GxE SNP in human 
adipose tissue, and the previous TWAS analyses have shown that the imputed local adipose 
expression of LDB3 is significantly associated with BMI and related cardiometabolic 
phenotypes32,33. Notably, individuals with nonsynonymous mutations in exon 6 of LDB3 
have been shown to exhibit autosomal dominant myofibrillar myopathy characterized by 
fatty degeneration (i.e. steatosis) of the muscle that progresses with age37,38. This is 
suggestive of the role of lipid metabolism in the pathophysiology of these variants. Here we 
show that the accessibility of the promoter region is increased in response to lipid challenge 
in human adipocytes, and adipocyte nuclear protein binds to the GxE SNP site. Although we 
did not detect LDB3 expression in our cultured adipocytes, we found that the gene is 
expressed in mature adipocytes isolated from human adipose biopsies, i.e. in vivo, 
suggesting that future studies to understand the role of LDB3 in adipocytes may require in 
vivo mouse models. In line with this, LDB3 is known to bind alpha-actinin isoforms that are 
not muscle-specific, and actin cytoskeleton organization is critically important in 
maintaining proper tissue functions. Taken together with the adipose cis-eQTL and TWAS 
results, our lipid challenge results provide a functional mechanism for the GxE effect in 
human adipocytes, adding to our knowledge of environmental response to diet and the 
consequent effects on genetic predisposition to cardiometabolic traits in humans.
The 154 lipid-responsive promoters within adipocyte chromosomal interactions provide a set 
of biologically important genes for studies in the adipose tissue. These gene regions have a 
higher conservation score, and the 154 genes are more likely to be loss-of-function (LoF) -
intolerant than expected by chance, suggesting that there are evolutionary constraints to 
maintain their proper function. The LoF-intolerant genes are widely and highly expressed19, 
and they may exhibit pleiotropy. Nonetheless, the lipid-responsive mechanism of genomic 
regulation identified for the LoF-intolerant genes in this study provides evidence that these 
genes may be important in maintaining energy homeostasis, which is critical for survival.
It is known that dietary saturated fat intake is correlated with various adverse 
cardiometabolic outcomes25,27, and a GRS for obesity-related traits was previously shown to 
interact with saturated fat (SF) intake to affect BMI26. However, as the authors of that study 
note, the underlying mechanisms for the GxEs remain elusive, particularly when the effect is 
estimated across tens of SNPs26. Here we bridge this knowledge gap, and show through a 
genome-wide scan of regulatory open chromatin responses to saturated versus 
monounsaturated fat uptake that a subset of these responses are likely specific to saturated 
fat intake and, when dysregulated at the genetic level, could underlie GWAS and GxE 
signals for cardiometabolic traits. We note that we assessed the effects of exogenous fatty 
acids and did not quantify the consequent cellular fatty acid processing, which could include 
desaturation of palmitic acid (C16:0) to the monounsaturated fatty acid, palmitoleic acid 
(C16:1), by stearoyl-CoA desaturase (SCD). Thus, we do not know whether the effects we 
see at the DNA level are directly due to the SFA signaling, or whether these effects result 
from downstream signaling mechanisms of the SCD pathway, affecting MUFA 
concentrations inside the cell.
Our finding that the SNPs within the cis regions of the 154 lipid-responsive gene promoters 
(gene body +/− 500 kb) contribute significantly to the heritability of serum lipid levels 
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suggests that responses to lipid uptake in adipocytes are associated with cellular programs 
that can modulate serum lipid levels. Correspondingly, we identified 5 adipocyte lipid-
responsive, interacting gene promoters and 3 lipid-responsive enhancers that harbor genome-
wide significant signals for serum lipid traits, including the well-known nutrient-sensing 
FADS1/2/3 gene cluster. Specific lipid-associated SNPs within this locus have undergone 
positive selection in Inuits, thought to be in response to the polyunsaturated fatty acids 
(PUFAs) in high marine mammalian fat diets39. Furthermore, a gene-diet interaction for 
PUFA intake has been identified in Europeans at the FADS1/2/3 locus40, and while many 
studies of the effects of FADS1/2 polymorphisms on PUFA metabolism have shown a clear 
role for this locus in modulating serum fatty acid levels, an understanding of the mechanistic 
effects of these SNPs, associated with cardiometabolic disorders, have been less 
conclusive41,42. Our results suggest that the underlying mechanisms may derive from the 
effects of saturated fats at this locus. This additional role for a well-established yet 
inconclusive locus supports the applicability of our approach to identify GxEs through 
molecular genomic responses to relevant environmental stimuli.
While there has been a strong international effort by the scientific community to characterize 
genomic regulatory elements in various cell types and tissues, many of the publicly available 
datasets and the corresponding genomic annotations were created in cells at steady or 
unstimulated baseline states43–46. Context-specific molecular genomics studies have mainly 
been performed in immune cell types47–49; however, similar studies in other cell types are 
scarce. In line with the importance of studying molecular genomic phenotypes under 
physiologically relevant conditions, we found here that whereas most lipid-responsive 
regions in human adipocytes reside in known adipocyte enhancers, a subset emerge from 
regions that were not identified as open chromatin, and were annotated as quiescent8, in 
unchallenged adipocytes, indicating that quiescent regions of the human genome are 
activated under specific environmental contexts. Thus, this genome-wide scan for response 
to fatty acid uptake in adipocytes adds to the currently incomplete understanding of genomic 
regulation in contexts that are expected to confer complex cardiometabolic disease states.
In conclusion, this study highlights the value of performing genome-wide functional 
genomics experiments in a context-specific manner to advance our understanding of 
environmental epigenomic responses underlying complex traits. We obtained a global 
assessment of genomic responses of human primary adipocytes to dietary fatty acid uptake, 
through incorporating open chromatin and chromosomal interaction data that we followed 
for GxEs in UK Biobank. Overall, our study helped discover candidate functional 
mechanisms at 38 novel gene-diet interactions on BMI, identified over 100 genes important 
for lipid uptake that may contribute to variance in cardiometabolic traits, and uncovered a 
new set of interacting open chromatin elements responding to lipid challenge in a primary 
human cell type relevant for lipid synthesis and storage.
Materials and Methods
Cell lines and culture reagents
We obtained and cultured the primary human white preadipocyte cells as recommended by 
PromoCell (PromoCell C-12731, lot 395Z024) for preadipocyte growth and differentiation 
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into adipocytes. Cell media (PromoCell) was supplemented with 1% penicillin-
streptomycin. We maintained the cells at 37ºC in a humidified atmosphere at 5% CO2. For 
the lipid challenge experiments in the adipocytes, we serum-starved for 16 hours using 0.5% 
fetal calf serum (FCS) in supplemented adipocyte basal medium (PromoCell), prior to 
treatment with 200 µM palmitic acid:BSA, 200 µM oleic acid:BSA complex (Sigma Alrich 
O3008), or 0.23% fatty acid free bovine serum albumin (BSA, Sigma Aldrich A8806) as a 
vehicle control, in media containing 0.5% FCS for 24 hours prior to performing 
experiments.
Palmitic acid conjugation to bovine serum albumin
We dissolved 25.6 mg palmitic acid (PA, Sigma Aldrich P5585) into 1 mL 0.15 M NaCl at 
70ºC in a shaking heat block to make 100 mM PA. We added the PA solution dropwise into 
10% w/v BSA in 0.15 M NaCl at 37ºC to make PA:BSA conjugate at 8 mM stock PA.
Oil red o staining and quantification
We prepared oil red o (ORO) stock by making 0.3% ORO in >99% isopropanol and filtering 
through a 0.45 μm filter. This was diluted 3:2 ORO:H2O, incubated at room temperature 
(RT) for 10 minutes, and then filtered through a 0.22 μm filter. We fixed cells for 30-60 
minutes in 10% formalin, rinsed with distilled water, and incubated 2-5 minutes at RT with 
60% isopropanol. We stained with ORO for 15 minutes, rinsed well with water, and 
collected images for quantification. Cells were photographed with a Keyence bright-field, 
light microscope under 10x magnification for publication images and 20x magnification for 
lipid droplet (LD) quantification. LD numbers were counted for ~20 cells per condition 
(untreated, BSA, PA, and OA). The total area of ORO staining was quantified using 
ImageJ50.
Assay for transposase accessible chromatin (ATAC) –sequencing
We performed the ATAC-seq protocol in the untreated primary human preadipocytes and 
adipocytes in 300,000 nuclei in three biological replicates per cell type, similarly as 
developed in Buenrostro et al.5 Specifically, we lysed cells in ice-cold lysis buffer (10 mM 
Tris-HCl pH 7.4, 10 mM NaCl, 3 mM MgCl2) plus 0.03-0.1% Tween-20 for 10 minutes on 
ice. We centrifuged at 4°C, 500 x g for 10 minutes, and then resuspended the nuclear pellet 
in 50 ul of transposition master mix (25 ul 2x TDE1 buffer, 2.5 ul transposase, 22.5 ul 
nuclease-free water; Illumina FC-121-1030). We incubated at 37ºC for 30 minutes, and then 
purified the DNA with the Qiagen MinElute kit (Qiagen 28204). Libraries were amplified 
using 6 cycles and sequenced on the Illumina HiSeq 4000 to produce an average of 
23,376,290 (+/− 3,337,206) reads.
For the ATAC-seq in primary human adipocytes that underwent lipid challenge, we 
performed omni-ATAC as developed in Corces et al.51 in 300,000 nuclei in three biological 
replicates per condition. Specifically, we treated the cells with DNase I (Worthington, 200 
U/ml) at 37°C for 30 minutes, trypsinized the cells and resuspended in 50 ul of ice-cold lysis 
buffer (10 mM Tris-HCl pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% Igepal CA-630, 0.1% 
Tween-20, and 0.01% digitonin) and incubated on ice for 3 minutes. We washed with 1 ml 
ice-cold lysis quench (10 mM Tris-HCl pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% 
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Tween-20) and centrifuged at 4°C, 500 x g for 10 minutes. The nuclear pellet was 
resuspended in 50 ul transposition master mix (25 ul 2x TDE1 buffer, and 2.5 ul transposase, 
16.5 ul PBS, 0.5 ul 1% digitonin, 0.5 ul 10% Tween-20, and 5 ul nuclease-free water). We 
incubated at 37ºC for 30 minutes with mixing at 1000 RPM, and then purified the DNA with 
the Qiagen MinElute kit. Libraries were amplified using 6-7 cycles and sequenced on the 
Illumina HiSeq 4000 to produce an average of 40,315,572 (+/−14,577,770) reads.
ATAC-seq data processing and peak calling
We processed the sequencing reads and performed quality control using the ENCODE 
ATAC-seq Data Standards and Prototype Processing Pipeline. Briefly, we aligned reads to 
the human reference genome (GRCh37/hg19) using Bowtie252 v2.2.9 (with parameters -k 4 
-X 2000 --local), filtered out unpaired mapped reads and reads with MAPQ < 30 
(Samtools53) and duplicates (marked with Picard Tools). Only reads from the autosomes and 
the X chromosome were retained for downstream analyses.
Identification of differentially accessible ATAC-seq peaks
Read alignments from all untreated human preadipocyte and adipocyte (3 biological 
replicates per cell type) libraries were merged prior to peak calling. Peaks were called using 
MACS254 v2.1.1 (using the BEDPE function) and peaks with an FDR < 0.05 were retained. 
We filtered out peaks in blacklisted regions and peaks that did not replicate in two out of the 
three biological replicates in at least one condition. For differential accessibility analyses, we 
retained peaks with counts per million (cpm) >= 1 in at least 3 libraries. We then input 
aligned read counts per peak into cqn55 v1.20.0 and normalized the counts for GC content, 
peak length, and library size before inputting the counts into edgeR56 v3.16.5 to detect 
differentially accessible peaks between the preadipocytes and adipocytes using the 
generalized linear model (GLM) functionality and quasi-likelihood (QL) F-test and an FDR 
threshold of 0.05. Libraries for the adipocyte lipid challenge ATAC-seq were processed 
identically up until the differential accessibility analysis. To detect open chromatin regions 
that exhibit differential accessibility in the lipid-challenged adipocytes, we performed a one-
way analysis of variance (ANOVA) using the GLM functionality and QL F-test functionality 
in edgeR56 and an FDR threshold of 0.05. For the post hoc test to determine which 
comparison was significant after the one-way ANOVA (OA vs. BSA, PA vs. BSA, or OA vs. 
PA), we determined the least significant difference.
Transcription factor motif enrichment in ATAC-peaks
We used Hypergeometric Optimization of Motif EnRichment (HOMER, v4.9)6 to 
investigate the enrichment of motif sequences in the open chromatin regions. For the 
enrichment in differentially accessible peaks between untreated preadipocytes and 
adipocytes, we used the consensus peak set (i.e. all peaks that were called both in the 
preadipocyte and adipocyte data) as the background. We utilized the de novo motif 
enrichment functionality. To ensure that our background input file was not biasing the 
results, we also performed the same analysis with the genome as the background input, 
which produced largely the same results, with smaller p-values (data not shown). For the 
enrichment in lipid-responsive peaks in adipocyte promoter-enhancer contacts, we used non-
differentially accessible peaks within the promoter-enhancer contacts as the background. 
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Due to the small number of peaks (n=264), we used the known TF motif enrichment 
functionality.
Hi-C library preparation
We prepared the Hi-C libraries for the primary human adipocyte lipid challenge experiment 
as described in Pan et al.15 in two biological replicates per condition (BSA, OA, and PA). 
These methods were adapted by closely following in-nucleus Hi-C methods in Rao et al.57 
and Nagano et al.58 Specifically, we fixed 7-10 M adherent cells directly in the culture plate 
in 2% formaldehyde and quenched with glycine to a final concentration of 125 mM. Cells 
were lysed in ice-cold lysis buffer (10 nM Tris-HCl pH 8.0, 10 mM NaCl, 0.2% Igepal 
CA-630, and 1X protease inhibitors: cOmplete™, EDTA-free Protease Inhibitor cocktail) on 
ice for 30 minutes with occasional agitation. We split into 5M nuclei aliquots, and 
centrifuged at 2500 x g for 5 min at 4°C. The nuclear pellets were resuspended in 50 ul of 
0.5% SDS in 1X NEBuffer 2 (New England Biolabs) and incubated at 62ºC for 10 minutes. 
We then added 145 ul water and 25 ul 10% Triton X-100 and incubated at 37°C for 15 
minutes and digested chromatin by adding 25 ul 10X NEBuffer 2 and 400 U of HindIII 
(New England Biolabs), incubating at 37°C overnight with shaking (950 rpm).
The next day, we marked the DNA ends with biotin [1.5 ul 10 mM dATP, 1.5 ul 10 mM 
dGTP, 1.5 ul 10 mM dTTP, 37.5 ul 0.4 mM biotin-14-dCTP (Invitrogen), and 8 ul 5U/μl 
Klenow (New England Biolabs)], incubating for 60 min at 37°C; then added 895 ul ligation 
mix [663 ul of water, 120 ul of 10X NEB T4 DNA ligase buffer, 100 ul of 10% Triton 
X-100, 12 ul of 10 mg/ml bovine serum albumin, and 5μl of 400 U/μl T4 DNA Ligase (New 
England Biolabs)]. Ligation was performed at room temperature for 4 hours with slow 
rotation, then 50 ul of 20 mg/ml proteinase K and 120 μl of 10% SDS were added and 
incubated at 55°C for 30 minutes. We added 130 ul of 5 M NaCl and incubated at 68°C 
overnight. We then performed an ethanol precipitation and sheared the purified DNA to 
250-550 bp using the Covaris M220 instrument. Double-size selection was performed using 
the SPRI select agent (Beckman Coulter) by adding 0.55X volume and then 0.15X volume 
according to manufacturer’s instructions, eluting the final DNA in 300 ul 10 mM Tris pH 
8.0.
Biotin pulldown was performed using 150 ul of 10 mg/ml DYNAL™ MyOne™ 
Dynabeads™ Streptavidin T1 (Invitrogen 65601) per sample. First, the beads were washed 
twice with 400 ul 1X Tween Washing Buffer (1X TWB: 5mM Tris-HCl (pH 7.5); 0.5mM 
EDTA; 1M NaCl; 0.05% Tween 20), then they were resuspended in 300 ul of 2X Binding 
Buffer (2X BB: 10mM Tris-HCl (pH 7.5); 1mM EDTA; 2M NaCl) and added to the 300 ul 
of sheared and size-selected DNA. We incubated at room temperature for 15 minutes with 
rotation to bind biotinylated DNA to the streptavidin beads. We washed twice with mixing at 
55°C with 600 ul 1X TWB, then washed beads in 100 ul 1X NEB T4 DNA ligase buffer and 
repaired the ends of the DNA by resuspending beads in 100 ul master mix (88 ul of 1X NEB 
T4 DNA ligase buffer with 10 mM ATP 2 ul of 25 mM dNTP mix, 5 ul of 10 U/ul NEB T4 
PNK, 4 ul of 3 U/ul NEB T4 DNA polymerase I, 1 ul of 5 U/ul NEB DNA polymerase I, 
Large (Klenow) Fragment) and incubated at room temperature for 30 minutes. We washed 
twice again with 1X TWB, once in 1X NEBuffer 2, then resuspended 100 ul of dATP 
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attachment master mix (90 ul of 1X NEBuffer 2, 5 ul of 10 mM dATP, 5 ul of 5 U/ul NEB 
Klenow exo minus) and incubated for 30 minutes at 37ºC. We washed twice in 1X TWB 
then resuspended beads in 100 ul 1X T4 DNA ligase buffer. We followed the Agilent 
SureselectXT manufacturer instructions to ligate the paired-end adapters. The beads were 
then washed twice with 1X TWB, resuspended in 32 ul 1X Tris buffer, and DNA was 
removed from the streptavidin beads by heating at 98ºC for 10 minutes. We then followed 
the Agilent SureSelectXT manufacturer instructions for the pre-capture PCR, using 8 cycles.
Promoter Capture Hi-C library preparation
The RNA baits were designed in Mifsud et al.14 for capturing HindIII fragments containing 
gene promoters (Dr. Cameron Osborne kindly shared the exact design). As described in 
Mifsud et al.14, 120-mer RNA baits were designed to target both ends of HindIII fragments 
that contain annotated gene promoters (Ensembl promoters of protein-coding, noncoding, 
antisense, snRNA, miRNA and snoRNA transcripts). The bait sequence was deemed valid if 
GC content ranged from 25-65%, contained less than 3 consecutive Ns, and was within 330 
bp of HindIII fragment ends. The Hi-C library hybridization to the capture library was 
performed according to Agilent SureSelectXT manufacturer instructions. A total of 550 ng of 
the Hi-C library was hybridized to the biotinylated RNA baits, captured with DYNAL™ 
MyOne™ Dynabeads™ Streptavidin T1 beads, and amplified in a post-capture PCR to add 
indexes, using 12 PCR cycles. The library was sequenced on the Illumina HiSeq 4000 
platform. All six libraries were sequenced together across 2 lanes on the Illumina HiSeq 
4000 to produce an average of 127,069,374 (+/−16,855,586) sequencing reads per library.
Capture Hi-C data processing and interaction calling
We processed the sequencing reads as described in Pan et al.15, using the Hi-C User Pipeline 
(HiCUP) v0.5.959 default settings except the insert size restrictions for the filtering step were 
set to 200-600 bp. We called significant interactions on each library separately with the 
Capture Hi-C Analysis of Genome Organization (CHiCAGO) software v1.1.160. We used 
the default threshold of 5 for calling significant interactions. To create a stringent set of 
interactions, we merged all pCHi-C final alignments and called interactions using 
CHiCAGO, again using a threshold of 5; then filtered these interactions to include only 
those that were called in both biological replicates in at least one condition (BSA, OA, PA).
Cross-species conservation analysis
For the across-species conservation analysis, we used the PhastCons score18 available on the 
UCSC ENCODE database. Briefly, the PhastCons score uses a phylo-HMM to predict the 
per-base conservation across species. We used the PhastCons scores for placental mammal 
alignment and calculated the mean score for each of the lipid-responsive regions for the 
protein-coding lipid responsive genes on autosomes (gene body +/−500 kb). To create a 
background set for this comparison, we calculated the mean score for all other protein-
coding genes annotated by Ensembl in GRCh37 and their surrounding regions of +/− 500kb. 
We performed a non-parametric two-sided Wilcoxon signed-rank test to compare the lipid-
responsive regions to the background set.
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LD score analysis
We used LD-score regression24 to estimate the heritability explained by the lipid-responsive 
regions. More specifically, we generated an annotation for each lipid-responsive region 
consisting of the lipid-responsive gene (gene body +/−500 kb) and used the summary 
statistics from the lipid GWAS study11 to estimate the proportion of heritability explained by 
the 154 lipid-responsive promoters or 323 promoters that interact with lipid-responsive 
enhancers in adipocytes, for the four lipid GWAS traits: serum triglycerides, HDL 
cholesterol, LDL cholesterol, and total cholesterol.
Genotype and phenotype data from the UK Biobank cohort
We downloaded the imputed genotype data from the UK Biobank cohort4. We identified all 
of the SNPs in the lipid-responsive gene promoters involved in chromosomal interactions. 
For the GxE interaction test, we filtered out the SNPs that had genotype missing rate more 
than 5% or the minor allele frequency (MAF) less than 5%. We used the BMI value 
collected from the initial UK Biobank assessment visit at which the participants were 
recruited. The 24-hour recall of saturated fat consumption in diet was collected at 5 different 
time points including the initial assessment and 4 online-cycle collections. If an individual 
had the 24-hour recall of the saturated fat collected at multiple time points, we used the 
value closest to the initial assessment. We then selected the unrelated Caucasian individuals 
from the UK Biobank participants who had both BMI and saturated fat diet data collected 
for the GxE analysis. We corrected BMI for the following covariates and performed inverse 
normal transformation to ensure that BMI is normally distributed: Array type, sex (inferred), 
age (when attended assessment center), age2, the assessment center ID, and genetic principle 
components of 1-20.
Genome-wide GxE scan
To verify that our significant GxE interactions were not caused by an overall inflation, we 
fitted the linear GxE interaction model on all SNPs across the human genome in the 
UKBiobank data. We first selected the SNPs that are not in the same LD block (r2 < 0.2) and 
then used the following linear model to detect the GxE between each LD pruned SNP and 
saturated fat intake on BMI:
Y = α + βGg + βEe + βGEge + ε Equation 1:
Y is a vector of inverse normalized transformed BMI values and g represents the vector of 
number of minor alleles in the genotypes of the target SNP for the individuals in the study 
sample. We use e for the vector of saturated fat intake levels as the environmental covariate 
and ε represents a vector of random errors, in which each entry is independently and 
normally distributed. The α and β are the estimated parameters. The test for an interaction is 
based on the coefficient βGE. A non-zero βGE indicates that there is an interaction between 
the genotype and environment factor for the outcome phenotype. We constructed a Q-Q plot 
to compare the p-values of βGE and the expected p-values based on the multiple testing.
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Testing for GxE using multi-variable linear model
We used the following multi-variable linear model to detect the GxEs between the SNPs and 
saturated fat intake for BMI:
Y = α + βEe +
i 1
N
(βGi gi)
i 1
N
(βGEi gie) ε Equation 2:
Y is a vector of inverse normalized transformed BMI values and gi represents a vector of the 
number of minor alleles in the genotypes of the target SNP i, i=1, …, N SNPs, for the 
individuals in the study sample. We use e for the vector of saturated fat intake levels as the 
environmental covariate and ε represents a vector of random errors, in which each entry is 
independently and normally distributed. The α and βs are the estimated parameters. The 
significance of the interaction is given for the coefficient βGEi. A non-zero βGEi indicates 
that there is an interaction between the genotype i and environment factor (i.e. the 24-hour 
saturated fat recall) for the outcome phenotype (i.e. BMI). Individual βGEi are estimated 
conditioned on the effects of the other genotypes and βGi from the multi-variable linear 
model. The p-values given for the individual βGEi are calculated using t-tests.
Electrophoretic mobility shift assay
Nuclear protein was extracted from adipocytes using the nuclear protein extraction kit 
(Active Motif 40010) following manufacturer instructions. Oligonucleotide probes (15 bp 
flanking SNP site for the reference or alternate allele) (Supplementary Table 21) with a 
biotin tag at the 5’ end of the forward sequence (Integrated DNA Technologies) were 
incubated with human adipocyte nuclear protein and the working reagent from the Gelshift 
Chemiluminescent EMSA kit (Active Motif 37341). For competitor assays, an unlabeled 
probe of the same sequence was added to the reaction mixture at 100X excess. The reaction 
was incubated for 30 minutes at room temperature, and then loaded on a 6% retardation gel 
(ThermoFisher Scientific EC6365BOX) that was run in 0.5X TBE buffer. We transferred the 
contents of the gel to a nylon membrane, and visualized with the chemi-luminescent reagent 
as recommended.
Cis-expression quantitative trait loci in the METSIM cohort
We obtained the subcutaneous adipose cis-eQTL variants identified in the RNA-seq data 
(n=335) from the Finnish METSIM cohort15,31.
Reporting summary
Detailed information on experimental design and reagents is also collected on our Reporting 
Summary, which is published alongside this paper.
Data Availability
The human primary preadipocyte and adipocyte (untreated and lipid-challenged) ATAC-seq 
data; and the human primary adipocyte promoter Capture Hi-C data in the lipid-challenged 
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conditions have been deposited in GEO under accession code GSE129574 and are available 
upon request from the corresponding author.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Differential ATAC-seq analysis between human primary preadipocytes and adipocytes 
indicates successful adipocyte differentiation and wide-spread changes in chromatin accessibility.
(a) Bright-field images of preadipocytes (top) and in vitro differentiated adipocytes (bottom) 
for unstained cells (left) and cells stained with oil red o (right). Images are representative 
examples from 2 independent experiments. (b) Heatmaps show log2 fold-change (log2FC) of 
bins per million mapped reads (BPM) for preadipocytes compared to adipocytes in the three 
indicated peak sets. FDR was calculated (adjusting for n=154,647 ATAC-seq peaks) from 
the p-values of the QL F-test (see Methods) for differential accessibility between 
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preadipocytes and adipocytes using ATAC-seq libraries from n=3 replicates per cell type. 
The top enriched transcription factor motif for the indicated peak set is listed (right). 
Enrichment p-values are derived from the hypergeometric enrichment test of the proportion 
of the given top de novo identified6 TF motifs in the 3 indicated peak sets compared with the 
background set (see Methods). (c,d) Read coverage (BPM) in one representative (out of n=3 
replicates per cell type) preadipocyte (blue) and adipocyte (red) ATAC-seq library at the 
adipocyte-accessible ATAC-peaks in the promoters of (c) the adipocyte hormone gene, 
adiponectin (ADIPOQ) and (d) the adipocyte-specific marker, peroxisome proliferator-
activated receptor gamma coactivator 1-alpha (PPARGC1A). PAd indicates preadipocytes; 
and Ad, adipocytes.
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Figure 2. Lipid-responsive regions fall within adipocyte-accessible regions of the genome, as well 
as within context-dependent regions that are not present in untreated adipocytes.
(a) Schematic overview of the lipid challenge experiment in human primary adipocytes. The 
treatments were performed in 3 replicates per condition. (b) Schematic overview indicates 
the two categories of lipid-responsive peaks used for all downstream analyses. Peaks were 
considered differentially accessible at a cutoff of FDR < 0.05. FDR was calculated 
(adjusting for n=122,252 ATAC-seq peaks) from the p-values of the QL F-test (see Methods) 
in the one-way ANOVA. Significant lipid-responsive peaks categorized as adipocyte-
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accessible (n=570) or “context-dependent” (i.e. not identified in untreated preadipocytes or 
adipocytes; n=453) were used in all downstream analyses. (c,d) Violin plots show the 
log2FC of the differentially accessible peaks in the indicated comparisons, stratified by 
whether the peak was (c) adipocyte-accessible, or (d) context-dependent. (c) The violin plot 
characteristics are as follows: MUFA vs. ctrl (n=419) range: −1.07 – 1.25; median: 0.26; 
25th percentile: −0.34; and 75th percentile: 0.42. SFA vs. ctrl (n=87) range: −1.17 – 0.77; 
median: 0.15; 25th percentile: −0.34; and 75th percentile: 0.27. SFA vs. MUFA (n=321) 
range: −1.22 – 1.21; median: −0.26; 25th percentile: −0.48; and 75th percentile: 0.43. (d) The 
violin plot characteristics are as follows: MUFA vs. ctrl (n=284) range: −1.05 – 1.40; 
median: −0.33; 25th percentile: −0.53; and 75th percentile: 0.37. SFA vs. ctrl (n=99) range: 
−1.19 – 1.02; median: 0.34; 25th percentile: 0.20; and 75th percentile: 0.47. SFA vs. MUFA 
(n=301) range: −1.30 – 1.21; median: 0.49; 25th percentile: −0.19; and 75th percentile: 0.65. 
Box indicates shift toward increased accessibility in SFA-treated cells, specifically observed 
in the context-dependent peaks. (e) Human genome browser snapshot (WashU) of the 
GPAM locus, which harbors 15 lipid-responsive peaks in a ~50-kb region (highlighted in 
blue vertical rectangles). Fourteen of these peaks are SFA-responsive. Read coverage (BPM) 
in one representative (of n=3 replicates per condition) control (red), MUFA (green), and SFA 
(blue) ATAC-seq library. The serum lipid GWAS SNPs are categorized as being in the lipid-
responsive peak (red) or outside of the lipid-responsive peak (grey). MUFA indicates 
monounsaturated fatty acids; SFA, saturated fatty acids; PAd, preadipocytes; and Ad, 
adipocytes.
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Figure 3. The 154 genes with lipid-responsive promoters within chromosomal interactions 
exhibit cross-species conservation and constraints on loss-of-function mutations, in line with 
their potential importance for energy homeostasis and survival.
(a) The top 10 enriched TF motifs in the lipid-responsive open chromatin regions in 
adipocyte chromosomal interactions (n=264) include key TFs in lipid metabolism, such as 
the co-factors PPARG, and RXR. **FDR < 0.001; ***FDR < 0.0001. Enrichment p-values 
were derived from the hypergeometric enrichment test of proportion of the given TF motif in 
the peak set compared with the background set of peaks (all non-lipid-responsive peaks in 
adipocyte chromosomal interactions), adjusted (Benjamini-Hochberg) for the number of 
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known motifs tested (n=364)6. (b) Schematic of the data we integrated to identify the 154 
genes with lipid-responsive promoters in adipocyte chromosomal interactions. (c) Density 
plot shows the distribution of per-gene average conservation scores across placental 
mammals18 for all protein-coding genes in the genome (n=19,316) compared to all protein-
coding genes in the set of 154 genes with lipid-responsive promoters (n=114). *depicts the 
p-value for two-sided Wilcoxon signed-rank test. (d) Bar graph shows the proportion of 
protein-coding genes that are loss-of-function intolerant (i.e. are unlikely to have protein-
truncating variants in humans)19 in the whole genome (n=3,204/18,122; 17.7%) compared to 
the protein-coding genes among the 154 genes (n=27/104; 26.0%). LoF indicates loss-of-
function; *depicts the p-value for the hypergeometric enrichment test.
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Figure 4. A lipid-responsive open chromatin region in human primary adipocytes at chr11q12.2 
FADS1/2/3 locus harbors GWAS SNPs for serum lipid traits.
(a) Genome browser snapshot shows the FADS1/2/3 locus with adipocyte baseline ATAC-
seq [one representative example from n=3 vehicle control (BSA) ATAC-seq libraries] and 
pCHi-C data (interactions identified in at least one condition from the adipocyte lipid 
challenge pCHi-C are included; see Methods). The FADS2 promoter chromosomal 
interactions are highlighted in magenta. (b) Read coverage (BPM) in one representative (out 
of n=3 replicates per condition) vehicle control (red), MUFA (green), and SFA (blue) ATAC-
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seq library. The lipid-responsive peak in one of the FADS2 promoters is more accessible in 
SFA- compared to MUFA-treated adipocytes and contains 3 independent GWAS SNPs for 
serum lipid traits (1 indicates rs191508698; 2, rs968567; and 3, rs99780). **FDR was 
calculated (adjusting for n=122,252 ATAC-seq peaks) from the p-values of the QL F-test 
(see Methods) in the one-way ANOVA. For the post hoc test to determine which comparison 
was significant after the one-way ANOVA (MUFA vs. ctrl, SFA vs. ctrl, or SFA vs. MUFA), 
we determined the least significant difference; n.s. indicates non-significant (based on the 
post hoc test of the one-way ANOVA); MUFA, monounsaturated fatty acids; and SFA, 
saturated fatty acids.
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Figure 5. Fine-mapping of the gene-diet interaction for BMI at the LDB3 promoter region.
(a) Genome-browser snapshot of the LDB3 locus with adipocyte baseline ATAC-seq [one 
representative example from n=3 vehicle control (BSA) ATAC-seq libraries] and pCHi-C 
data (interactions identified in at least one condition from the adipocyte lipid challenge 
pCHi-C are included; see Methods). The LDB3 promoter interactions are highlighted in 
magenta. (b) Read coverage (BPM) in one representative (out of n=3 replicates per 
condition) control (red), MUFA (green), and SFA (blue) ATAC-seq library. The lipid-
responsive ATAC-seq peak harboring the significant GxE SNP rs10788522 resides in the 
LDB3 gene. (c) Electrophoretic mobility shift assay (EMSA) shows binding of adipocyte 
nuclear protein to the GxE SNP rs10788522. *FDR was calculated (adjusting for n=122,252 
ATAC-seq peaks) from the p-values of the QL F-test (see Methods) in the one-way ANOVA. 
For the post hoc test to determine which comparison was significant after the one-way 
ANOVA (MUFA vs. ctrl, SFA vs. ctrl, or SFA vs. MUFA), we determined the least 
significant difference; n.s. indicates non-significant (based on the post hoc test of the one-
way ANOVA); and ±depicts the p-value for the βGEi for rs10788522 from the multi-variable 
linear model testing for GxEs in the UK Biobank.
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Figure 6. Analytical approach.
Flowchart of our approach to integrate molecular genomics data created in human 
adipocytes in physiologically relevant contexts, that, when combined with human cohort 
molecular and phenotype data, enables the detection of GxE signals.
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